Cargando…
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
There has been a recent emergence of novel targeted agents for treatment of Hodgkin and non-Hodgkin lymphoma. In particular, antibodies and antibody-drug conjugates directed against surface antigens, agents that block immune checkpoint pathways, and small molecule inhibitors directed against cell si...
Autores principales: | Grover, Natalie S., Park, Steven I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588185/ https://www.ncbi.nlm.nih.gov/pubmed/26393619 http://dx.doi.org/10.3390/ph8030607 |
Ejemplares similares
-
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017) -
The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
por: Meier, Jeremy A., et al.
Publicado: (2022) -
Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
por: Minson, Adrian, et al.
Publicado: (2022) -
Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994) -
Genetic lesions and targeted therapy in Hodgkin lymphoma
por: Li, Zhe, et al.
Publicado: (2023)